First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT

First patient exceeding 5-year complete remission after ²²⁵Ac-PSMA-TAT

Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):311-312. doi: 10.1007/s00259-020-04875-y. Epub 2020 May 28.

¹ Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. hendrik.rathke@med.uni-heidelberg.de.
² European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
³ Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
⁴ Urology Center Mannheim, Mannheim, Germany.
⁵ Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.

No abstract available